Can Peripheral Arterial Tonometry and Biomarkers Help Identify Women Who Will Have Progressively Worsening Hypertensive Disorders of Pregnancy?
American Journal of Perinatology · 01.03.2025 · 42 (04) · 511-519
DOI: 10.1055/a-2407-1761 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2025. Verfasst von Caitlin M Clifford und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Manometry, Vascular Endothelial Growth Factor Receptor-1, Hypertension, Pregnancy-Induced, Natriuretic Peptide, Brain. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to (1) evaluate whether endothelial dysfunction, as measured by peripheral arterial tonometry (PAT) indices and biomarker (soluble fms-like tyrosine kinase-1 [sFLT], brain natriuretic peptide [BNP]) levels at 34 weeks gestation, can predict progression from nonsevere to severe hypertensive disorders of pregnancy (HDPs); and (2) develop a clinical risk model for prediction of progression from nonsevere to severe HDP. Study Design We prospectively enrolled patients with a singleton gestation carrying a nonsevere HDP diagnosis. Forty-five participants were enrolled for PAT evaluation and serum collection between 340/7 and 366/7 weeks. PAT indices (e.g., Augmentation Index normalized to a heart rate of 75 bpm [AI75]) and biomarker concentrations were assessed at enrollment. The primary outcome was progression from a nonsevere diagnosis in the late preterm period to a diagnosis of preeclampsia with severe features or superimposed preeclampsia. Statistical analyses included two-sample t-tests, Fisher's exact tests, and multivariate modeling.
Results
Thirteen subjects (30%) progressed to severe disease. No significant differences in mean PAT indices between the outcome groups were found. We found a significant difference in mean sFLT values between the two groups (p = 0.02, area under the curve [AUC] of 0.609), but not in mean BNP values. An endothelial dysfunction index (presence of fetal growth restriction, “high” AI75, and positive systolic blood pressure slope) discriminated between progression and nonprogression (p = 0.03, AUC of 0.707). Conclusion sFLT level was a marker of progression from nonsevere to severe HDP. Further, a novel endothelial dysfunction index discriminated between progression and nonprogression to severe disease with good performance. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
- Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.
Zitieren
APA
Clifford, C. M., Hesson, A. M., Sangtani, A., Ganesh, S. K., & Langen, E. S. (2025). Can Peripheral Arterial Tonometry and Biomarkers Help Identify Women Who Will Have Progressively Worsening Hypertensive Disorders of Pregnancy?. American Journal of Perinatology, 42(04), 511-519. https://doi.org/10.1055/a-2407-1761
Vancouver
Clifford CM, Hesson AM, Sangtani A, Ganesh SK, Langen ES. Can Peripheral Arterial Tonometry and Biomarkers Help Identify Women Who Will Have Progressively Worsening Hypertensive Disorders of Pregnancy?. American Journal of Perinatology. 2025;42(04):511-519. doi:10.1055/a-2407-1761
BibTeX
@article{Clifford2025,
author = {Clifford, Caitlin M and Hesson, Ashley M and Sangtani, Ajleeta and Ganesh, Santhi K and Langen, Elizabeth S},
title = {Can Peripheral Arterial Tonometry and Biomarkers Help Identify Women Who Will Have Progressively Worsening Hypertensive Disorders of Pregnancy?},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {04},
pages = {511--519},
doi = {10.1055/a-2407-1761}
}
EUVIMED